Colospan
Formerly Cologuard
Technology for Colorectal Surgery
Startup Seed Health Tech & Life Sciences Est. 2010
🌐 WebsiteLinkedIn
Total Raised
$17M
Seed
Last Round
$9.3M
3 rounds
Investors
6
6 public
Team
3
11-50 employees
Confidence
92/100
News
7
articles
Patents
1
About
Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and divert colonic stomas. The companys lead product is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal matter and the anastomotic site.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
gastroenterologysurgerymedical-devicessurgical-instrumentssurgeonspreventiontreatmentscancercolonoscopyhospitals
Funding & Events
Sep 2017
Undisclosed Round $7.7M
Anatomy Medical Technology Fund, Docor International Management, AMIT-Technion ( The Alfred Mann Institute), Triventures, Clal Biotechnology Industries (CBI)
Mar 2017
Non-equity Undisclosed
EU Horizon 2020
Dec 2021
Undisclosed Round $9.3M
European Innovation Council (EIC)
News (7)
Feb 21, 2022 · www.blechman.co.il
growth-positive
שיתוף פעולה מנצח בין בלכמן מנס וקולוספן בתחום הביוטק
PartnersExpand
Dec 20, 2021 · www.einnews.com
growth-positive
Colospan receives €8.2 million from the European Innovation Council for its novel colorectal surgery device
Investment
Oct 5, 2021 · www.prnewswire.com
growth-positive
Colospan accelerates FDA pivotal trial and appoints medtech veteran, Gregory D. Casciaro, to the Board of Directors
Management Changes
Dec 9, 2020 · www.prnewswire.com
growth-positive
Henry Ford Hospital First in the U.S. to Test Novel CG-100 Intraluminal Device in patients undergoing colorectal anastomosis
PartnersCustomers
Jan 20, 2020 · www.hospimedica.com
growth-positive
Gastrointestinal Bypass Device Offers an Alternative to Diverting Stoma
Customers
Jan 8, 2020 · www.prnewswire.com
growth-positive
Colospan Announces FDA Approval of IDE for Intraluminal Bypass Device - an Alternative Approach to Diverting Stoma
InvestmentPartnersCustomers
Sep 27, 2017 · www.globes.co.il
growth-positive
Clinical leakage prevention co Colospan raises $7.7m
Investment
Details
Product Stage
Clinical Trial
Employees
11-50
Exact Count
11
District
Center District
Founded
2010
Registrar
514525971
Crunchbase
colospan
Locations
Atir Yeda Street 21, Kefar Sava, Israel
125 Cambridgepark Dr, Cambridge, MA 02140, USA
Links
Website
colospan.com/
LinkedIn
Profile
Facebook
Page
Admin
Last Update
Dec 22, 2021
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
not claimed
Team (3)
Michal Geva
Board Member
Boaz Assaf
Founder & CEO
Founder
Tamir Peleg
Sales & Marketing Manager
Finder · Colospan · 2026